INITIATING ANTI-IL-5 THERAPY IN SEVERE ASTHMA: BASELINE OBSERVATIONS AND SWITCHING OF BIOLOGICAL AGENTS

Ruane L.; Leahy E.; Weibel N.; Heke E.; Macdonald M.; Bardin P.

首页> 外文期刊>Respirology : >INITIATING ANTI-IL-5 THERAPY IN SEVERE ASTHMA: BASELINE OBSERVATIONS AND SWITCHING OF BIOLOGICAL AGENTS

【24h】

INITIATING ANTI-IL-5 THERAPY IN SEVERE ASTHMA: BASELINE OBSERVATIONS AND SWITCHING OF BIOLOGICAL AGENTS

机译：在严重的哮喘中启动抗IL-5治疗：基线观察和生物药物的转换

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Respirology :》 |2019年第s1期|共1页
作者
Ruane L.; Leahy E.; Weibel N.; Heke E.; Macdonald M.; Bardin P.;
展开▼
作者单位

Monash Univ &

Hosp Melbourne Vic Australia;

Monash Univ &

Hosp Melbourne Vic Australia;

Monash Univ &

Hosp Melbourne Vic Australia;

Monash Univ &

Hosp Melbourne Vic Australia;

Monash Univ &

Hosp Melbourne Vic Australia;

Monash Univ &

Hosp Melbourne Vic Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. INITIATING ANTI-IL-5 THERAPY IN SEVERE ASTHMA: BASELINE OBSERVATIONS AND SWITCHING OF BIOLOGICAL AGENTS [J] . Ruane L., Leahy E., Weibel N., Respirology : . 2019,第S1期

机译：在严重的哮喘中启动抗IL-5治疗：基线观察和生物药物的转换
2. Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents [J] . Hande Celiker, Haluk Kazokoglu, Haner Direskeneli BMC Ophthalmology . 2018,第1期

机译：严重的贝塞特葡萄膜炎的常规免疫抑制疗法：生物制剂的转换率
3. Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study [J] . Mustafa Abdo, Henrik Watz, Vera Veith, Respiratory Research . 2020,第1期

机译：小气道功能障碍作为预测因子和标志物，用于严重嗜酸性哮喘生物治疗的临床反应：纵向观察研究
4. Finite element analysis for severe asthma therapy at the airway smooth muscle by radiofrequency ablation [C] . Ruxsapong P., Phasukkit P., Tungjitkusolmun S., The 5th Biomedical Engineering International Conference. . 2012

机译：射频消融治疗气道平滑肌重度哮喘的有限元分析
5. Part I. Design, synthesis and biological evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents. Part II. Development of novel taxoid-based drug conjugates and theranostic imaging agents towards tumor-targeted chemotherapy. [D] . Park, Bora. 2014

机译：第一部分：针对FtsZ作为抗结核药的新型2,5,6-三取代苯并咪唑的设计，合成和生物学评估。第二部分新型基于紫杉醇的药物结合物和治疗诊断剂在肿瘤靶向化疗中的应用。
6. Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents [O] . Hande Celiker, Haluk Kazokoglu, Haner Direskeneli 2018

机译：重度贝塞特葡萄膜炎的常规免疫抑制疗法：生物制剂的转换率
7. 4CPS-142 Effectiveness and safety of anti-IL-5 biologic agents in severe eosinophilic asthma [O] . M Calvo Arbeloa, G Pinilla Lebrero, E Lacalle Fabo, 2020

机译：4CPS-142严重嗜酸性哮喘抗IL-5生物剂的有效性和安全性

INITIATING ANTI-IL-5 THERAPY IN SEVERE ASTHMA: BASELINE OBSERVATIONS AND SWITCHING OF BIOLOGICAL AGENTS

著录项

相似文献

相关主题

期刊订阅